Study Name:
A Randomized Phase III Trial of Maintenance Chemotherapy Comparing 12, Monthly Cycles of Single Agent Paclitaxel or XYOTAX (CT-2103) (IND#70177), No Treatment Until Documented Relapse in Women with Advanced Ovarian or Primary Peritoneal Cancer Who Achieve a Complete Clinical Response to Primary Platinum/Taxane Chemotherapy.
|
|
Purpose:
This randomized phase III trial is studying paclitaxel to see how well it works compares to polyglutamate paclitaxel or observation only in treating patients with stage III or stage IV ovarian epithelial or peritoneal cancer or fallopian tube cancer.
|
|
Study Type: Treatment
Protocol: UIC 2005-0641 GOG 212
|
|
For study details, click here.
Internal users only: click here for protocol details and forms
|
Back to Oncology Clinical Trials Homepage